Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease

World Journal of Gastroenterology

Volumn 20, Issue 5, 2014, Pages 1127-1138

  Lee, In Ah ^a   Kamba, Alan ^a   Low, Daren ^a   Mizoguchi, Emiko ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherent invasive escherichia coli; Chitinase 3 like 1; Chitinase inhibitors; Host microbial interactions; Inflammatory bowel disease; Intestinal epithelial cells

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ALLOSAMIDIN; BETA CATENIN; CAFFEINE; CHITINASE; CHITINASE 3 LIKE 1 PROTEIN; CIMETIDINE; CVT 6883; GLYCOPROTEIN; LEUKOTRIENE; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; PHENYTOIN; PHOSPHODIESTERASE; PROTEIN KINASE B; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALGORITHM; ALLERGIC ASTHMA; ANXIETY DISORDER; ARTICLE; BACTERIAL INFECTION; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; DEPRESSION; DIZZINESS; DRUG EFFICACY; EDEMA; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; IC 50; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSOMNIA; MANIA; NAUSEA; NONHUMAN; PROTEIN EXPRESSION; PSYCHOSIS; RESTLESSNESS; SIGNAL TRANSDUCTION; TACHYCARDIA;

ADHERENT-INVASIVE ESCHERICHIA COLI; CHITINASE 3-LIKE 1; CHITINASE INHIBITORS; HOST-MICROBIAL INTERACTIONS; INFLAMMATORY BOWEL DISEASE; INTESTINAL EPITHELIAL CELLS;

ADIPOKINES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHITINASE; DRUG DESIGN; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; LECTINS; SIGNAL TRANSDUCTION; XANTHINES;

EID: 84893081846     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i5.1127     Document Type: Article

References (87)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535 [PMID: 11247898]
2. Mizoguchi E. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 2006; 130: 398-411 [PMID: 16472595 DOI: 10.1053/j.gastro.2005.12.007]
3. Chen CC, Llado V, Eurich K, Tran HT, Mizoguchi E. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/ YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol 2011; 140: 268-275 [PMID: 21546314 DOI: 10.1016/j.clim.2011.04.007]
4. Kanneganti M, Kamba A, Mizoguchi E. Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol 2012; 5: 1-9 [PMID: 23439988]
5. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008; 358: 1682-1691 [PMID: 18403759 DOI: 10.1056/NEJMoa0708801]
6. Eurich K, Segawa M, Toei-Shimizu S, Mizoguchi E. Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 2009; 15: 5249-5259 [PMID: 19908331]
7. Low D, Tran HT, Lee IA, Dreux N, Kamba A, Reinecker HC, Darfeuille-Michaud A, Barnich N, Mizoguchi E. Chitinbinding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis. Gastroenterology 2013; 145: 602-612.e9 [PMID: 23684751 DOI:10.1053/j.gastro.2013.05.017]
8. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, de Vries CJ. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 687-694 [PMID: 10073974]
9. Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, Ostergaard K, Løvgreen-Nielsen P, SonneHolm S, Lorenzen I. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001; 9: 203-214 [PMID: 11300743 DOI: 10.1053/ joca.2000.0377]
10. Rao FV, Andersen OA, Vora KA, Demartino JA, van Aalten DM. Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes. Chem Biol 2005; 12: 973-980 [PMID: 16183021 DOI: 10.1016/j.chembiol.2005.07.009]
11. Andersen OA, Dixon MJ, Eggleston IM, van Aalten DM. Natural product family 18 chitinase inhibitors. Nat Prod Rep 2005; 22: 563-579 [PMID: 16193156 DOI: 10.1039/b416660b]
12. Andrews KW, Schweitzer A, Zhao C, Holden JM, Roseland JM, Brandt M, Dwyer JT, Picciano MF, Saldanha LG, Fisher KD, Yetley E, Betz JM, Douglass L. The caffeine contents of dietary supplements commonly purchased in the US: analysis of 53 products with caffeine-containing ingredients. Anal Bioanal Chem 2007; 389: 231-239 [PMID: 17676317 DOI:10.1007/s00216-007-1437-2]
13. Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 2011; 94: 1113-1126 [PMID: 21880846 DOI: 10.3945/ajcn.111.016667]
14. Peck JD, Leviton A, Cowan LD. A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update. Food Chem Toxicol 2010; 48: 2549-2576 [PMID: 20558227 DOI: 10.1016/ j.fct.2010.06.019]
15. Lee IA, Low D, Kamba A, Llado V, Mizoguchi E. Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells. J Gastroenterol 2013; Epub ahead of print [PMID: 23925589 DOI: 10.1007/s00535-013-0865-3]
16. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996; 98: 945-953 [PMID: 8770866 DOI: 10.1172/JCI118878]
17. Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 246-259 [PMID: 12902848]
18. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8: 564-577 [PMID: 20622892 DOI: 10.1038/nrmicro2403]
19. Sartor RB. Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research. J Pediatr Gastroenterol Nutr 2005; 40 Suppl 1: S30-S31 [PMID: 15805841]
20. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434 [PMID: 17653185 DOI: 10.1038/nature06005]
21. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317 [PMID: 21677747 DOI: 10.1038/nature10209]
22. Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, de Jong YP, Ooi CJ, Xavier RJ, Terhorst C, Podolsky DK, Bhan AK. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology 2002; 122: 134-144 [PMID: 11781288]
23. Mizoguchi E, Xavier RJ, Reinecker HC, Uchino H, Bhan AK, Podolsky DK, Mizoguchi A. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology 2003; 125: 148-161 [PMID: 12851880]
24. Schultsz C, Moussa M, van Ketel R, Tytgat GN, Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 1997; 50: 573-579 [PMID: 9306938]
25. Burke DA, Axon AT. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ 1988; 297: 102-104 [PMID: 3044496]
26. Sartor RB, DeLa Cadena RA, Green KD, Stadnicki A, Davis SW, Schwab JH, Adam AA, Raymond P, Colman RW. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. Gastroenterology 1996; 110: 1467-1481 [PMID: 8613052]
27. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-1404 [PMID: 7729631]
28. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004; 99: 2376-2384 [PMID: 15571586 DOI:10.1111/j.1572-0241.2004.40417.x]
29. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115: 1405-1413 [PMID: 9834268]
30. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999; 67: 4499-4509 [PMID: 10456892]
31. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421 [PMID: 15300573]
32. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 2002; 292: 185-193 [PMID: 12398209 DOI: 10.1078/1438-4221-00201]
33. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, Darfeuille-Michaud A. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009; 206: 2179-2189 [PMID: 19737864 DOI: 10.1084/jem.20090741]
34. Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW. Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem 2003; 278: 37753-37760 [PMID: 12851408 DOI: 10.1074/jbc.M303137200]
35. Ling H, Recklies AD. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 2004; 380: 651-659 [PMID: 15015934 DOI: 10.1042/BJ20040099]
36. Henrissat B, Davies G. Structural and sequence-based classification of glycoside hydrolases. Curr Opin Struct Biol 1997; 7: 637-644 [PMID: 9345621]
37. Kawada M, Chen CC, Arihiro A, Nagatani K, Watanabe T, Mizoguchi E. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Lab Invest 2008; 88: 883-895 [PMID: 18490894 DOI: 10.1038/labinvest.2008.47]
38. Morimoto K, Karita S, Kimura T, Sakka K, Ohmiya K. Cloning, sequencing, and expression of the gene encoding Clostridium paraputrificum chitinase ChiB and analysis of the functions of novel cadherin-like domains and a chitinbinding domain. J Bacteriol 1997; 179: 7306-7314 [PMID: 9393694]
39. Watanabe T, Ito Y, Yamada T, Hashimoto M, Sekine S, Tanaka H. The roles of the C-terminal domain and type III domains of chitinase A1 from Bacillus circulans WL-12 in chitin degradation. J Bacteriol 1994; 176: 4465-4472 [PMID: 8045877]
40. Kamba A, Lee IA, Mizoguchi E. Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer. Curr Mol Med 2013; 13: 1110-1121 [PMID: 23170831]
41. Kanneganti M, Mino-Kenudson M, Mizoguchi E. Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011; 2011: 342637 [PMID: 21274454 DOI: 10.1155/2011/342637]
42. Rao FV, Houston DR, Boot RG, Aerts JM, Sakuda S, van Aalten DM. Crystal structures of allosamidin derivatives in complex with human macrophage chitinase. J Biol Chem 2003; 278: 20110-20116 [PMID: 12639956 DOI: 10.1074/jbc. M300362200]
43. Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R. Insights into the regulation of TNF-alpha production in human mononuclear cells: The effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo) 2008; 63: 321-328 [PMID: 18568240]
44. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 1999; 159: 508-511 [PMID: 9927365 DOI: 10.1164/ajrccm.159.2.9804085]
45. Howell RE. Multiple mechanisms of xanthine actions on airway reactivity. J Pharmacol Exp Ther 1990; 255: 1008-1014 [PMID: 2175791]
46. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 2005; 174: 589-594 [PMID: 15634873]
47. Ukena D, Schudt C, Sybrecht GW. Adenosine receptorblocking xanthines as inhibitors of phosphodiesterase isozymes. Biochem Pharmacol 1993; 45: 847-851 [PMID: 7680859]
48. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002; 195: 583-592 [PMID: 11877481]
49. Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996; 118: 1727-1735 [PMID: 8842438]
50. Obiefuna PC, Batra VK, Nadeem A, Borron P, Wilson CN, Mustafa SJ. A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydr o-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma. J Pharmacol Exp Ther 2005; 315: 329-336 [PMID: 16020631 DOI: 10.1124/ jpet.105.088179]
51. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414: 916-920 [PMID: 11780065 DOI: 10.1038/414916a]
52. Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D. Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 2007; 320: 1246-1251 [PMID: 17159162 DOI: 10.1124/jpet.106.112250]
53. Tang H, Sun Y, Shi Z, Huang H, Fang Z, Chen J, Xiu Q, Li B. YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration. J Immunol 2013; 190: 438-446 [PMID: 23197259 DOI: 10.4049/jimmunol.1201827]
54. Chen CC, Pekow J, Llado V, Kanneganti M, Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M, Mizoguchi E. Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol 2011; 179: 1494-1503 [PMID: 21763261 DOI: 10.1016/ j.ajpath.2011.05.038]
55. Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 2009; 28: 4456-4468 [PMID: 19767768 DOI: 10.1038/onc.2009.292]
56. Huang XL, Xu J, Zhang XH, Qiu BY, Peng L, Zhang M, Gan HT. PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm Res 2011; 60: 727-734 [PMID: 21442372 DOI: 10.1007/s00011-011-0325-6]
57. Dahan S, Roda G, Pinn D, Roth-Walter F, Kamalu O, Martin AP, Mayer L. Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology 2008; 134: 192-203 [PMID: 18045591 DOI: 10.1053/ j.gastro.2007.10.022]
58. Managlia E, Katzman RB, Brown JB, Barrett TA. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells. Inflamm Bowel Dis 2013; 19: 2051-2060 [PMID: 23867870 DOI:10.1097/MIB.0b013e318297d741]
59. Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, Barrett TA, Bentrem DJ, Beckhove P, Khazaie K. PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitisinduced cancer. Clin Cancer Res 2013; 19: 2342-2354 [PMID: 23487439 DOI: 10.1158/1078-0432.CCR-12-2623]
60. Sheng H, Shao J, Townsend CM, Evers BM. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 2003; 52: 1472-1478 [PMID: 12970141]
61. Claessen MM, Schipper ME, Oldenburg B, Siersema PD, Offerhaus GJ, Vleggaar FP. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance. Cell Oncol 2010; 32: 303-310 [PMID: 20208143 DOI: 10.3233/CLO-2009-0503]
62. Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, Brown JB, May R, Yang GY, Ragheb JW, Evers BM, Weber CR, Turner JR, He XC, Katzman RB, Li L, Barrett TA. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 2010; 139: 869-881, e1-9 [PMID: 20580720 DOI: 10.1053/j.gastro.2010.05.037]
63. Fukumoto S, Hsieh CM, Maemura K, Layne MD, Yet SF, Lee KH, Matsui T, Rosenzweig A, Taylor WG, Rubin JS, Perrella MA, Lee ME. Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem 2001; 276: 17479-17483 [PMID: 11278246 DOI: 10.1074/jbc.C000880200]
64. Brown JB, Lee G, Managlia E, Grimm GR, Dirisina R, Goretsky T, Cheresh P, Blatner NR, Khazaie K, Yang GY, Li L, Barrett TA. Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology 2010; 138: 595-605, e1-3 [PMID: 19879273 DOI: 10.1053/ j.gastro.2009.10.038]
65. He CH, Lee CG, Dela Cruz CS, Lee CM, Zhou Y, Ahangari F, Ma B, Herzog EL, Rosenberg SA, Li Y, Nour AM, Parikh CR, Schmidt I, Modis Y, Cantley L, Elias JA. Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2. Cell Rep 2013; 4: 830-841 [PMID: 23972995 DOI: 10.1016/ j.celrep.2013.07.032]
66. Peterson TC, Peterson MR, Raoul JM. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. Eur J Pharmacol 2011; 662: 47-54 [PMID: 21554874 DOI: 10.1016/j.ejphar.2011.04.030]
67. Peterson TC, Davey K. Effect of acute pentoxifylline treatment in an experimental model of colitis. Aliment Pharmacol Ther 1997; 11: 575-580 [PMID: 9218085]
68. Murthy S, Cooper HS, Yoshitake H, Meyer C, Meyer CJ, Murthy NS. Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment Pharmacol Ther 1999; 13: 251-260 [PMID: 10102957]
69. Reimund JM, Dumont S, Muller CD, Kenney JS, Kedinger M, Baumann R, Poindron P, Duclos B. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease. Gut 1997; 40: 475-480 [PMID: 9176074]
70. Sakuda S, Isogai A, Matsumoto S, Suzuki A. Search for microbial insect growth regulators. II. Allosamidin, a novel insect chitinase inhibitor. J Antibiot (Tokyo) 1987; 40: 296-300 [PMID: 3570982]
71. Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004; 304: 1678-1682 [PMID: 15192232 DOI: 10.1126/science.1095336]
72. Vaaje-Kolstad G, Houston DR, Rao FV, Peter MG, Synstad B, van Aalten DM, Eijsink VG. Structure of the D142N mutant of the family 18 chitinase ChiB from Serratia marcescens and its complex with allosamidin. Biochim Biophys Acta 2004; 1696: 103-111 [PMID: 14726210]
73. Zheng T, Rabach M, Chen NY, Rabach L, Hu X, Elias JA, Zhu Z. Molecular cloning and functional characterization of mouse chitotriosidase. Gene 2005; 357: 37-46 [PMID: 16005164 DOI: 10.1016/j.gene.2005.05.006]
74. Boot RG, Blommaart EF, Swart E, Van der Vlugt G., Hauharali K., Bijl N., Moe C, Place A, Aerts JM. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 2001; 276: 6770-6778 [PMID: 11085997 DOI:10.1074/jbc.M009886200]
75. Sutherland TE, Maizels RM, Allen JE. Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy 2009; 39: 943-955 [PMID: 19400900 DOI: 10.1111/ j.1365-2222.2009.03243.x]
76. Schüttelkopf AW, Andersen OA, Rao FV, Allwood M, Lloyd C, Eggleston IM, van Aalten DM. Screening-based discovery and structural dissection of a novel family 18 chitinase inhibitor. J Biol Chem 2006; 281: 27278-27285 [PMID: 16844689 DOI: 10.1074/jbc.M604048200]
77. Sutherland TE, Andersen OA, Betou M, Eggleston IM, Maizels RM, van Aalten D, Allen JE. Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor. Chem Biol 2011; 18: 569-579 [PMID: 21609838 DOI: 10.1016/j.chembiol.2011.02.017]
78. Omura S, Arai N, Yamaguchi Y, Masuma R, Iwai Y, Namikoshi M, Turberg A, Kölbl H, Shiomi K. Argifin, a new chitinase inhibitor, produced by Gliocladium sp. FTD-0668. I. Taxonomy, fermentation, and biological activities. J Antibiot (Tokyo) 2000; 53: 603-608 [PMID: 10966076]
79. Arai N, Shiomi K, Yamaguchi Y, Masuma R, Iwai Y, Turberg A, Kölbl H, Omura S. Argadin, a new chitinase inhibitor, produced by Clonostachys sp. FO-7314. Chem Pharm Bull (Tokyo) 2000; 48: 1442-1446 [PMID: 11045447]
80. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992; 17: 139-170 [PMID: 1356551]
81. Graham TE, Hibbert E, Sathasivam P. Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol (1985) 1998; 85: 883-889 [PMID: 9729561]
82. Kent M. Food and Fitness: A Dictionary of Diet and Exercise. England: Oxford University Press, 1997
83. Yew D. Caffeine Toxicity Clinical Presentation. 2013 Available from: URL: http://emedicine.medscape.com/article/821863-clinical
84. Ward A, Clissold SP. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50-97 [PMID: 3308412]
85. Pentoxifylline. 2013 Available from: URL: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a685027.html
86. Theophylline. 2012 Available from: URL: http://www.drugs.com/pro/theophylline.html
87. Alboni P, Menozzi C, Brignole M, Paparella N, Gaggioli G, Lolli G, Cappato R. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation 1997; 96: 260-266 [PMID: 9236443]